Clinical Laserthermia Systems AB (publ) (CLS-B) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.106x

Based on the latest financial reports, Clinical Laserthermia Systems AB (publ) (CLS-B) has a cash flow conversion efficiency ratio of -0.106x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.73 Million ≈ $-508.92K USD) by net assets (Skr44.50 Million ≈ $4.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CLS-B market cap for the company's overall valuation and market capitalisation.

Clinical Laserthermia Systems AB (publ) - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Clinical Laserthermia Systems AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Clinical Laserthermia Systems AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Clinical Laserthermia Systems AB (publ) ranked by their cash flow conversion efficiency. See CLS-B debt coverage from operations to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Tembo Global Industries Limited NSE:TEMBO	0.191x
Marine Petroleum Trust NASDAQ:MARPS	-1.106x
AGROB Immobilien AG F:AGR	N/A
Banka BioLoo Limited NSE:BANKA	0.140x
Nubeva Technologies Ltd V:NBVA	-0.079x
Ecoscience International Berhad KLSE:0255	0.088x
Magna Polonia SA WAR:06N	-0.007x
Vanadium Resources Ltd AU:VR8	-0.009x

Annual Cash Flow Conversion Efficiency for Clinical Laserthermia Systems AB (publ) (2008–2025)

The table below shows the annual cash flow conversion efficiency of Clinical Laserthermia Systems AB (publ) from 2008 to 2025. View CLS-B live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr66.48 Million ≈ $7.15 Million	Skr-33.20 Million ≈ $-3.57 Million	-0.499x	+41.89%
2024-12-31	Skr65.69 Million ≈ $7.07 Million	Skr-56.45 Million ≈ $-6.08 Million	-0.859x	+43.70%
2023-12-31	Skr43.53 Million ≈ $4.68 Million	Skr-66.45 Million ≈ $-7.15 Million	-1.527x	+83.01%
2022-12-31	Skr7.87 Million ≈ $846.40K	Skr-70.69 Million ≈ $-7.61 Million	-8.988x	-187.72%
2021-12-31	Skr21.18 Million ≈ $2.28 Million	Skr-66.17 Million ≈ $-7.12 Million	-3.124x	+21.47%
2020-12-31	Skr13.93 Million ≈ $1.50 Million	Skr-55.41 Million ≈ $-5.96 Million	-3.978x	+28.85%
2019-12-31	Skr7.00 Million ≈ $752.99K	Skr-39.12 Million ≈ $-4.21 Million	-5.591x	-619.15%
2018-12-31	Skr49.81 Million ≈ $5.36 Million	Skr-38.72 Million ≈ $-4.17 Million	-0.777x	-5.20%
2017-12-31	Skr33.00 Million ≈ $3.55 Million	Skr-24.39 Million ≈ $-2.62 Million	-0.739x	+35.74%
2016-12-31	Skr17.06 Million ≈ $1.84 Million	Skr-19.63 Million ≈ $-2.11 Million	-1.150x	-19.85%
2015-12-31	Skr19.46 Million ≈ $2.09 Million	Skr-18.68 Million ≈ $-2.01 Million	-0.960x	-92.50%
2014-12-31	Skr31.58 Million ≈ $3.40 Million	Skr-15.74 Million ≈ $-1.69 Million	-0.499x	+28.93%
2013-12-31	Skr26.09 Million ≈ $2.81 Million	Skr-18.30 Million ≈ $-1.97 Million	-0.702x	+0.45%
2012-12-31	Skr17.09 Million ≈ $1.84 Million	Skr-12.05 Million ≈ $-1.30 Million	-0.705x	-28.07%
2011-12-31	Skr10.83 Million ≈ $1.17 Million	Skr-5.96 Million ≈ $-641.36K	-0.550x	-15.89%
2010-12-31	Skr10.36 Million ≈ $1.11 Million	Skr-4.92 Million ≈ $-529.25K	-0.475x	-38.16%
2009-12-31	Skr6.63 Million ≈ $713.34K	Skr-2.28 Million ≈ $-245.16K	-0.344x	-1723.94%
2008-12-31	Skr3.68 Million ≈ $395.79K	Skr-69.30K ≈ $-7.46K	-0.019x	--

About Clinical Laserthermia Systems AB (publ)

ST:CLS-B Sweden Medical Devices

Market Cap

$9.40 Million

Skr87.33 Million SEK

Market Cap Rank

#27328 Global

#595 in Sweden

Share Price

Skr1.80

Change (1 day)

-1.42%

52-Week Range

Skr1.80 - Skr10.48

All Time High

Skr1089.26